SMMT
#721
Summit Therapeutics Inc. - Common Stock
17.1 3 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.62%
Variación mensual
-5.20%
Variación en los últimos 6 meses
-14.82%
Cambio anual
-13.75%
Cierres anteriores
17.5 9
Open
17.3 4
Mínimo
17.0 6
Máximo
17.5 9
Financials
- Market Capitalization 13.67 B
- Employee 265
- Founded 2004
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.15
Relación precio/flujo de caja
-21.44 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 706 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 216.75 USD | -0.76% | -8.31% | -12.49% | +54.82% | 14.07 B USD | ||
| 707 |  ASND Ascendis Pharma A/S - American Depositary Shares | 227.00 USD | -0.97% | -0.96% | -14.34% | +10.69% | 14.07 B USD | ||
| 744 |  CORT Corcept Therapeutics Incorporated - Common Stock | 121.19 USD | 0.00% | -0.83% | +6.89% | +65.18% | 13.10 B USD | ||
| 752 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 65.75 USD | +0.61% | -3.17% | -9.37% | +15.35% | 12.85 B USD |